Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y. | ||
Cons | - | - |
INDMoney rank | - | 14/21 | ||
Category,Subcateogry | Equity,Large & Mid-Cap | Equity,Large & Mid-Cap | ||
Fund Age | 5 Years | 12 Years | ||
Fund Size | 2784 Cr | 42981 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹1000 | SIP ₹99 Lumpsum ₹5000 | ||
Expense Ratio | 0.46% | 0.57% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | Nifty LargeMidcap 250 TR INR | Nifty LargeMidcap 250 TR INR |
No of Holdings | 71 | 92 | ||
Top 5 Holdings | Indus Towers Ltd Ordinary Shares (3.63%) ICICI Bank Ltd (3.26%) Glenmark Pharmaceuticals Ltd (3.05%) Divi's Laboratories Ltd (3.03%) State Bank of India (2.59%) | HDFC Bank Ltd (6.14%) Axis Bank Ltd (4.02%) State Bank of India (3.21%) ICICI Bank Ltd (3.16%) ITC Ltd (2.88%) | ||
No of Sectors | 11 | 13 | ||
Top 3 Sectors | Financial Services (31.63%) Health (18.26%) Industrial (14.4%) | Financial Services (29.93%) Consumer Cyclical (16.1%) Health (10.8%) | ||
Equity % | 96.08% | 99.03% | ||
Debt % | - | - | ||
P/E | - | - | ||
P/B | - | - | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.22% | 0.33% | ||
3-Month Return | 1.28% | 4.28% | ||
6-Month Return | -0.08% | 5.12% | ||
1-Year Return | -1.1% | 3.9% | ||
3-Year Return | 16.41% | 17.08% | ||
5-Year Return | 20.76% | 18.96% |
Sharpe | - | - | ||
Alpha | - | - | ||
Beta | - | - | ||
Standard Deviation | - | - | ||
Information Ratio | - | - |
Description | Mahindra Manulife Large & Mid Cap Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Mirae Asset Large & Midcap Fund Direct Plan Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kirti Dalvi | Neelesh Surana,Ankit Jain |